Recommended Motion Sickness Medications Available in Canada by Prescription
Transdermal scopolamine (Transderm-V) is the most effective prescription medication for motion sickness prevention available in Canada, with clinical studies showing 60-80% reduction in motion sickness symptoms compared to placebo. 1
First-Line Therapy: Scopolamine
Transdermal Scopolamine
- Formulation: Transdermal patch delivering approximately 1 mg over 3 days 2
- Dosing: Apply one patch to hairless area behind ear at least 4-6 hours before travel (ideally 8-12 hours for optimal effect) 2, 3
- Duration: Effective for up to 3 days; for longer trips, remove and apply new patch behind opposite ear 2
- Mechanism: Anticholinergic that blocks muscarinic receptors in the vestibular apparatus and vomiting center
- Efficacy: 60-80% reduction in motion sickness incidence and severity compared to placebo 3
Clinical Considerations for Scopolamine
Advantages:
Contraindications: 2
- Angle-closure glaucoma
- Hypersensitivity to scopolamine or belladonna alkaloids
- Dry mouth (50-60% of users)
- Drowsiness (up to 20%)
- Blurred vision (transient)
- Contact dermatitis at application site (10%)
Serious Adverse Effects (rare): 2
- Acute angle-closure glaucoma
- Neuropsychiatric reactions (confusion, hallucinations)
- Seizures (in predisposed individuals)
Second-Line Therapies
First-Generation Antihistamines
Dimenhydrinate (Gravol):
Promethazine:
Combination Therapy
For severe cases or when single agents are ineffective:
- Scopolamine + Antihistamine: May provide enhanced efficacy but with increased risk of side effects
- Scopolamine + Oral Scopolamine: For faster onset (apply patch + 0.3-0.6 mg oral dose 1 hour before travel) 3
Patient Selection Algorithm
For long journeys (>6 hours) or when oral therapy is ineffective:
- Transdermal scopolamine (first-line)
For shorter journeys or patients with contraindications to scopolamine:
- First-generation antihistamines (dimenhydrinate, promethazine)
For patients with history of severe motion sickness:
- Consider combination therapy
For patients with glaucoma, prostatic hypertrophy, or cognitive concerns:
- Avoid scopolamine; use antihistamines with caution
Important Clinical Pearls
- Apply scopolamine patch at least 4-6 hours before travel (ideally 8-12 hours for optimal effect) 3
- Wash hands thoroughly after application to avoid transferring medication to eyes 2
- Approximately 20-30% of patients may not achieve protective plasma concentrations with transdermal scopolamine 3
- Nonsedating antihistamines, ondansetron, and ginger root are not effective for motion sickness prevention 7
- Elderly patients and children are more sensitive to neurological and psychiatric effects of scopolamine 2
- For patients requiring rapid onset protection, consider combination of transdermal patch plus oral medication 3
Transdermal scopolamine remains the gold standard prescription medication for motion sickness prevention in Canada, offering superior efficacy with a favorable side effect profile compared to other available options 3, 1.